Potency assays and CMC approvals important for other studies to be approved to commence - A thought occurred to me about the importance of the potency assays and the CMC approvals and that is that approval of the assays and CMC issues being resolved was a pre-requisite for the commencement of other studies. From recollection ARDS and CLBP. Regardless of whether this constitutes a resubmission, acceptance of the assays and the CMC fixes is critically important to moving forward.
- Forums
- ASX - By Stock
- MSB
- Ann: Submits New Information to FDA IND File for SR-aGVHD
Ann: Submits New Information to FDA IND File for SR-aGVHD, page-294
-
- There are more pages in this discussion • 283 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.10 |
Change
-0.030(2.67%) |
Mkt cap ! $1.255B |
Open | High | Low | Value | Volume |
$1.12 | $1.13 | $1.09 | $2.828M | 2.568M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 53055 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 121233 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 35530 | 1.090 |
24 | 156548 | 1.085 |
25 | 314905 | 1.080 |
20 | 261805 | 1.075 |
15 | 573967 | 1.070 |
Price($) | Vol. | No. |
---|---|---|
1.095 | 121619 | 13 |
1.100 | 160537 | 17 |
1.105 | 172271 | 14 |
1.110 | 257441 | 7 |
1.115 | 48546 | 3 |
Last trade - 12.59pm 18/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |